CUPERTINO, Calif.--(BUSINESS WIRE)--NextBio, provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data, announced the launch of three new applications on the Elsevier SciVerse platform. SciVerse is an innovative new platform that integrates Elsevier’s key products and encourages the scientific community to collaborate on the development of customized search and discovery applications.
"These three new applications show the power of NextBio’s text-based search capabilities and are applicable to content beyond Life Sciences and Health Sciences,” said Dr. Satnam Alag, NextBio Vice President of Engineering. "The applications also demonstrate NextBio’s capabilities to search for relevant text not only at the document-level, but also at the sentence and paragraph level; to decompose an article into sub-sections; to find relevant content using faceted navigation; and to integrate content from Elsevier’s Scopus product."
The three new applications are:
- Matching Sentences application: this application enables a user to quickly search for matching sentences or paragraphs, create a custom clipboard document with references to the articles and sentences, which can be then printed or emailed.
- Methods Search application: this application enables a user to search for documents that has all the search terms mentioned in the methods section of the document.
- Prolific authors: this application uses Elsevier’s Scopus API to show the most prolific authors for a particular search term.
“Users typically print an article and then manually highlight relevant sentences/paragraphs. The matching sentences application streamlines this workflow by its powerful sentence/paragraph-level search and custom clipboard features. This application enables a user to very quickly go through a large number of search results, collecting relevant sentences/paragraphs on the way. The Matching Sentences application can save users hours of tedious work,” said Dr. Yibu Chen, Bioinformatics Specialist, University of Southern California.
“The new applications are an important part of the collaboration between our two companies. They also show the power of the SciVerse platform, by which technology companies and commercial and academic developers can leverage the SciVerse APIs and our content to build new solutions to enhance search and discovery experience of our users,” said Rafael Sidi, Elsevier Vice President of product management, ScienceDirect and knowledge discovery solutions.
“Our expertise in text-based search, ontology management, and semantic enrichment of content very nicely complements our unique data search and correlations engine. This is the first step in leveraging these capabilities within the NextBio platform,” said Saeid Akhtari, NextBio co-founder, President and Chief Executive Officer. “These new applications focus on the user’s workflow and help streamline the search process.”
For more information about SciVerse please visit http://www.sciverse.com.
NextBio is the provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data. NextBio’s platform seamlessly combines powerful tools with unique correlated content to transform information into knowledge, providing the foundation for new scientific discoveries. NextBio’s unique ‘correlation engine’ pre-computes billions of significant connections among public and private data and enables researchers to intelligently mine it in real-time. NextBio helps organizations increase productivity and dramatically improve collaboration across therapeutic groups and geographic boundaries. NextBio is delivered as a SaaS (Software as a Service) solution resulting in quick deployment and rapid return on investment.
Today, NextBio is used by researchers at the world's top commercial and academic institutions. NextBio’s enterprise solution has been deployed at Burnham Institute for Medical Research, Celgene, Eli Lilly, Genzyme, Johnson & Johnson, Merck, Regeneron, Scripps Research Institute, Stanford University, UCB, and Takeda, among many others. To learn more about NextBio, please visit our website at http://www.nextbio.com.
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).